The iLite® CD19 (+) Target Assay Ready Cells express the antigen CD19 on the cell surface and can be used as target cells in assay assessing Abs towards CD19.
iLite CD19 (+) Target Assay Ready Cells are genetically engineered human cells (Raji, ATCC# CCL-86) optimized to over-express the surface antigen CD19.
The cells can be used as target cells together with iLite® CD3 Effector Assay Ready Cells for measurement of bi-specific CD3-CD19 antibody activity.
FOR RESEARCH USE ONLY
|Technology||Cell-based reporter gene assay|
|Read-out of results||Quantitative,|
|Regulatory status||Research Use Only|
Get access to scientific material, posters and more.